Quantum eMotion Inc
QNC
Blue Horizon Global Capital Corp
BHCC
RAMM Pharma Corp
RAMM
Petrichor Energy Inc
PTP.H
Minaean SP Construction Corp
MSP
CA Stock MarketDetailed Quotes
DST Dundee Sustainable Technologies Inc
- 0.085
- +0.005+6.25%
15min DelayMarket Closed Dec 11 12:32 ET
5.67MMarket Cap-1.42P/E (TTM)
0.085High0.085Low1.00KVolume0.085Open0.080Pre Close85.00Turnover0.20052wk High0.01%Turnover Ratio66.70MShares0.04052wk Low-0.06EPS TTM1.25MFloat Cap7.400Historical HighLossP/E (Static)14.65MShs Float0.020Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-0.27P/B1Lot Size--Div YieldTTM
Dundee Sustainable Technologies Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -51.62%542.57K | -36.21%645.74K | -7.80%687.43K | -18.59%3.15M | -67.20%266.69K | 13.59%1.12M | 2.54%1.01M | -30.75%745.6K | -11.16%3.86M | -26.73%813.11K |
| Operating revenue | -51.62%542.57K | -36.21%645.74K | -7.80%687.43K | -18.59%3.15M | -67.20%266.69K | 13.59%1.12M | 2.54%1.01M | -30.75%745.6K | -11.16%3.86M | -26.73%813.11K |
| Cost of revenue | -65.01%304.89K | -55.80%362.68K | -37.54%394.94K | -36.23%1.96M | -147.97%-365.02K | 35.62%871.24K | -8.09%820.59K | -18.49%632.31K | -9.25%3.07M | -7.20%760.88K |
| Gross profit | -5.02%237.68K | 47.61%283.06K | 158.17%292.5K | 49.78%1.19M | 1,109.45%631.71K | -27.44%250.25K | 103.05%191.76K | -62.35%113.29K | -17.85%792.49K | -81.98%52.23K |
| Operating expense | -36.62%423.83K | 21.14%1.02M | -10.14%818.49K | -30.88%1.85M | -207.75%-565.67K | -23.13%668.66K | 30.89%838.38K | 41.40%910.8K | -3.49%2.68M | 2.63%525K |
| Selling and administrative expenses | -24.30%226.23K | 66.85%793.45K | -2.23%526.68K | 9.02%1.5M | -45.29%187.1K | -17.60%298.84K | 16.90%475.56K | 103.64%538.69K | -8.54%1.38M | 54.05%342.02K |
| -General and administrative expense | -24.30%226.23K | 66.85%793.45K | -2.23%526.68K | 9.02%1.5M | -45.29%187.1K | -17.60%298.84K | 16.90%475.56K | 103.64%538.69K | -8.54%1.38M | 54.05%342.02K |
| Research and development costs | -66.78%82.26K | -55.61%106.8K | -29.39%176.46K | -115.95%-129.96K | -1,528.40%-868.11K | -35.69%247.62K | 115.77%240.62K | -2.91%249.91K | 4.04%814.72K | -63.68%60.78K |
| Depreciation amortization depletion | -5.61%115.35K | -5.61%115.35K | -5.61%115.35K | -1.41%481.95K | -5.62%115.34K | -0.00%122.2K | -0.00%122.21K | 0.00%122.21K | 0.00%488.82K | 0.00%122.21K |
| -Depreciation and amortization | -5.61%115.35K | -5.61%115.35K | -5.61%115.35K | -1.41%481.95K | -5.62%115.34K | -0.00%122.2K | -0.00%122.21K | 0.00%122.21K | 0.00%488.82K | 0.00%122.21K |
| Operating profit | 55.51%-186.15K | -13.29%-732.54K | 34.05%-525.99K | 64.75%-665.17K | 353.27%1.2M | 20.30%-418.41K | -18.41%-646.62K | -132.35%-797.51K | -4.16%-1.89M | -113.21%-472.77K |
| Net non-operating interest income (expenses) | -179.49%-728.93K | -16.84%-707.74K | -28.56%-671.61K | 42.38%-1.11M | -73.53%-898.47K | 286.89%916.96K | -26.30%-605.72K | -19.32%-522.42K | -17.38%-1.93M | -9.20%-517.75K |
| Non-operating interest income | -99.58%6.64K | 14,036.67%4.24K | --0 | 4,026.12%1.37M | ---257.38K | 11,398.50%1.57M | --30 | 194.87%57.67K | 14.69%33.21K | --0 |
| Non-operating interest expense | 12.64%735.57K | 17.54%711.98K | 15.78%671.61K | 26.59%2.48M | 23.82%641.09K | 29.50%653.05K | 26.30%605.75K | 26.82%580.08K | 17.33%1.96M | 9.20%517.75K |
| Other net income (expenses) | -100.27%-2.7K | 108.75%2.26K | -1,396.63%-87.48K | -1,386.80%-488.9K | -1,658.03%-1.47M | 950.52%1.02M | -242.07%-25.85K | -184.78%-5.85K | -40.42%37.99K | -187.28%-83.78K |
| Gain on sale of security | -111.26%-2.7K | 108.75%2.26K | 282.12%10.65K | -174.36%-22.04K | 10.75%-14.34K | -17.19%24K | -306.03%-25.85K | -239.63%-5.85K | 153.78%29.64K | -41.11%-16.07K |
| Other non-operating income (expenses) | ---- | ---- | ---- | 10,825.80%912.85K | -16.52%-78.9K | 1,364.66%991.75K | ---- | ---- | -92.97%8.36K | -163.06%-67.71K |
| Income before tax | -160.61%-917.78K | -12.50%-1.44M | 3.07%-1.29M | 40.03%-2.26M | -9.28%-1.17M | 264.79%1.51M | -26.87%-1.28M | -71.25%-1.33M | -11.40%-3.77M | -79.08%-1.07M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -160.61%-917.78K | -12.50%-1.44M | 3.07%-1.29M | 40.03%-2.26M | -9.28%-1.17M | 264.79%1.51M | -26.87%-1.28M | -71.25%-1.33M | -11.40%-3.77M | -79.08%-1.07M |
| Net income continuous operations | -160.61%-917.78K | -12.50%-1.44M | 3.07%-1.29M | 40.03%-2.26M | -9.28%-1.17M | 264.79%1.51M | -26.87%-1.28M | -71.25%-1.33M | -11.40%-3.77M | -79.08%-1.07M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -161.80%-935.78K | -12.50%-1.44M | 3.07%-1.29M | 40.03%-2.26M | -9.28%-1.17M | 264.79%1.51M | -26.87%-1.28M | -71.25%-1.33M | -11.40%-3.77M | -79.08%-1.07M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -161.80%-935.78K | -12.50%-1.44M | 3.07%-1.29M | 40.03%-2.26M | -9.28%-1.17M | 264.79%1.51M | -26.87%-1.28M | -71.25%-1.33M | -11.40%-3.77M | -79.08%-1.07M |
| Diluted earnings per share | -150.00%-0.01 | 0.00%-0.02 | 0.00%-0.02 | 50.00%-0.03 | 50.00%-0.01 | 300.00%0.02 | 0.00%-0.02 | -100.00%-0.02 | -20.00%-0.06 | -100.00%-0.02 |
| Basic earnings per share | -150.00%-0.01 | 0.00%-0.02 | 0.00%-0.02 | 50.00%-0.03 | 50.00%-0.01 | 300.00%0.02 | 0.00%-0.02 | -100.00%-0.02 | -20.00%-0.06 | -100.00%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.